Profund Advisors’s Transmedics TMDX Stock Holding History

Profund Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,672	Closed	-$224K	–	1091
2025 Q2	$224K	Buy	+1,672	New	+$184K	0.01%	840
2024 Q4	–	Sell	-1,741	Closed	-$273K	–	1185
2024 Q3	$273K	Buy	+1,741	New	+$268K	0.01%	855

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Profund Advisors's TMDX Position: Q3 2025 in Review

Profund Advisors sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 1,672 shares — an estimated $224K sold.

Profund Advisors first reported a position in TMDX in Q3 2024 and held it in 2 quarters. The position peaked at $273K in Q3 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

Profund Advisors reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
Profund Advisors sold 1,672 Transmedics shares in Q3 2025, an estimated $224K.
Profund Advisors first reported a position in Transmedics in Q3 2024 and held it in 2 quarters.
Profund Advisors's Transmedics position peaked at $273K in Q3 2024.
388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Profund Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.